（Last updated : 2023-01-10 12:24:25）
  SEKI YOSHITAKA
   Department   The Jikei University School of Medicine  ,
   The Jikei University School of Medicine  ,
   Position   Assistant Professor
■ Journal
1. 　 Long-lasting response to afatinib that persisted after treatment discontinuation in a case of EGFR-mutated lung adenocarcinoma. 2019/01/31
■ Academic background
1. 2013/04～2016/03 Graduate School, Division of Medicine, Jikei University, Doctor of Medical Science
■ Presentation
1. How to Manage Toxicities of EGFR-TKI for Extreme Elderly Lung Cancer Patients: Supportive Care for Patients Aged 85 and Older （Poster notice，General） 2019/09/09
2. [P37-1] Liquid biopsy for the detection of the resistant mutation to ROS1 and RET inhibitors: A case series study （Poster notice，General） 2022/02/17
3. Impact of Corona Disaster on Life Outcomes of Patients with Small Cell Lung Cancer in Our Hospital （Poster notice，General） 2022/12/01
■ Main Subject
Respiratory　medicine
■ Belonging society
1. 2018～ European Society for Medical Oncology
■ researchmap Member ID
B000382343
■ Qualification and license
1. 2011/04/01 Diplomate, Subspecialty Board of Medical Oncology, JSMO Link
2. 2021/08/10 Senior fellow of the Japanese Respiratory Society
■ Home Page
   Division of Respirology, Department of Internal Medicine, The Jikei University Katsushika Medical Center, Japan
■ Present specialized field
Respiratory medicine 
■ External Researcher ID
orcID https://orcid.org/0000-0002-4108-9350
Researcher ID CAF-5787-2022